Myelodysplastic syndromes arising in patients with germline TP53 mutation and Li-Fraumeni syndrome

Archives of Pathology and Laboratory Medicine

Volumn 134, Issue 7, 2010, Pages 1010-1015

  Talwalkar, Sameer S ^a,b   Yin, C Cameron ^a   Naeem, Rizwan C ^b   Hicks, M John ^a   Strong, Louise C ^a   Abruzzo, Lynne V ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CASE REPORT; CHILD; CHROMOSOME 5; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; FAMILIAL CANCER; FATALITY; FEMALE; GENETICS; GLIOBLASTOMA; HUMAN; INFANT; KARYOTYPING; MALE; MIDDLE AGED; MUTATION; MYELODYSPLASTIC SYNDROME; PANCYTOPENIA; TUMOR SUPPRESSOR GENE;

CHILD; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 5; CYTOGENETIC ANALYSIS; FATAL OUTCOME; FEMALE; GENES, P53; GERM-LINE MUTATION; GLIOBLASTOMA; HUMANS; INFANT; KARYOTYPING; LEUKEMIA, MYELOID, ACUTE; LI-FRAUMENI SYNDROME; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PANCYTOPENIA;

EID: 77954332797     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Li FP, Fraumeni JF Jr. Soft tissue sarcomas, breast cancers and other neoplasms: a familial syndrome? Ann Intern Med. 1969;71(4):747-752.
2. Malkin D, Li FP, Strong LC, et al. Germ-line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science. 1990;250(4985):1233-1238.
3. Online Mendelian Inheritance in Man. Baltimore, MD: Johns Hopkins University. MIM 151623 (Li-Fraumeni syndrome 1; LFS1). http://www.ncbi.nlm. nih.gov/omim/. Accessed February 1, 2008.
4. Gonzalez KD, Noltner KA, Buzin CH, et al. Beyond Li-Fraumeni syndromes: clinical characteristics of families with p53 germline mutations. J Clin Oncol. 2008;27(8):1250-1256.
5. Li FP, Fraumeni JF Jr, Mulvihill JJ, et al. A cancer family syndrome in twentyfour kindreds. Cancer Res. 1988;48(18):5358-5362.
6. Lavigueur A, Maltby V, Mock D, Rossant J, Pawson T, Bernstein A. High incidence of lung, bone and lymphoid tumors in transgenic mice overexpressing mutant alleles of p53 oncogene. Mol Cell Bio. 1989;9(9):3982-3991.
7. Srivastava S, Zou ZQ, Pirollo K, Blattner W, Chang EH. Germ-line transmission of mutated p53 gene in cancer prone family with Li-Fraumeni syndrome. Nature. 1990;348(6303):747-749.
8. Santibanez-Koref MF, Birch JM, Hartley AL, et al. p53 germline mutations in Li-Fraumeni syndrome. Lancet. 1991;338(8781):1490-1491.
9. Felix CA, Nau MM, Takahashi T, et al. Hereditary and acquired p53 mutations in childhood acute lymphoblastic leukemia. J Clin Invest. 1992;89(2):642-647.
10. Malkin D, Jolly KW, Barbier N, et al. Germline mutations of the p53 tumor suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med. 1992;326(20):1309-1315.
11. Online Mendelian Inheritance in Man. Baltimore, MD: Johns Hopkins University. MIM 191170 (Tumor protein p53; TP53). http://www.ncbi.nlm.nih. gov/omim/. Accessed October 9, 2008.
12. Petitjean A, Achatz MIW, Borresen-Dale AL, Hainaut P, Olivier M. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene. 2007;26(15):2157-2165.
13. Law JC, Strong LC, Chidambaram A, Ferrell RE. A germline mutation in exon 5 of the p53 in an extended cancer family. Cancer Res. 1991;51(23, pt 1):6385-6387.
14. Felix CA, Hosler MR, Provisor D, et al. The p53 gene in pediatric therapyrelated leukemia and myelodysplasia. Blood. 1996;87(10):4376-4381.
15. Kuribayashi K, Matsunaga T, Sakai T, et al. A patient with TP53 germline mutation developed Bowen's disease and myelodysplastic syndrome with myelofibrosis after chemotherapy against ovarian cancer. Intern Med. 2005;44(5):490-495.
16. Anensen N, Skavland J, Stapnes C, et al. Acute myelogenous leukemia in a patient with Li-Fraumeni syndrome treated with valproic acid, theophyllamine and all-trans retinoic: a case report. Leukemia. 2006;20(4):734-736.
17. Brunning RD, Matutes E, Flandrin G, et al. Acute myeloid leukaemias and myelodysplastic syndromes, therapy related. In: Jaffe ES, Harris NL, Stein H, Vardiman J, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:89-91. World Health Organization Classification of Tumours; vol 3.
18. Schlette E, Lai R, Onciu M, Doherty D, Bueso-Ramos C, Medeiros Lj. Leukemic Mantle cell lymphoma: clinical and pathologic spectrum of twentythree cases. Mod Pathol. 2001;14(11):1133-1140.
19. Hwang SJ, Lozano G, Amos CI, Strong, L. C. Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk. Am J Hum Genet. 2003 (4);72:975-983.
20. Harlow E, Williamson NM, Ralston R, Helfman DM, Adams TE. Molecular cloning and in-vitro expression of a c-DNA clone for human cellular tumor antigen p53. Mol Cell Biol. 1985;5(7):1601-1610.
21. Petitjean A, Mathe E, Kato S, et al. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat. 2007;28(6):622-629.
22. Hall PA, McCluggage WG. Assessing p53 in clinical contexts: unlearned lessons and new perspectives. J Pathol. 2006;208(1):1-6.
23. Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89(6):2079-2088.
24. Wattel E, Preudhomme C, Hecquet B, et al. p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies. Blood. 1994;84(9):3148-3157.
25. Kita-Sasai Y, Horiike S, Misawa S, et al. International prognostic scoring system and TP53 mutations are independent prognostic indicators for patients with myelodysplastic syndrome. Br J Haematol 2001;115(2):309-312.
26. Horiike S, Kita-Sasai Y, Nakao M, Taniwaki M. Configuration of the TP53 gene as an independent prognostic parameter of myelodysplastic syndrome. Leuk Lymphoma. 2003;44(6):915-922.
27. Sugimoto K, Hirano N, Toyoshima H, et al. Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia. Blood. 1993;81(11):3022-3026.
28. Pedersen-Bjergaard J, Andersen MK, Andersen MT, Christiansen DH. Genetics of therapy-related myelodysplasia and acute myeloid leukemia. Leukemia. 2008;22(2):240-248.
29. Hisada M, Garber JE, Fung CY, Fraumeni JF Jr, Li FP. Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst. 1998;90(8):606-611.